Authors/Disclosures
|
Pierre Amarenco, MD
|
Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. The institution of Dr. Amarenco has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. Dr. Amarenco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for KOWA company. |
|
Oscar R. Benavente, MD, FRCP(C)
(Gordon and Leslie Diamond Health Care Centre)
|
No disclosure on file |
|
Larry B. Goldstein, MD, FAHA, FAAN
(University of Kentucky)
|
The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Michael G. Hennerici, MD
(Mannheim Universitats-Klinikum)
|
No disclosure on file |
|
|
No disclosure on file |
|
K. M. Welch, MB, ChB, FRCP
(Rosalind Franklin Univ of Medicine And Science)
|
No disclosure on file |
|
Justin A. Zivin, MD, PhD, FAAN
|
No disclosure on file |